Bispecific antibodies targeting mutant antigens and vitamin K-based feed additives represent distinct R&D tracks for treating T-cell malignancies and improving ruminant immune health.
Inadequate vitamin K levels in maternal livestock diets lead to poor colostrum quality and compromised neonatal immunity.
Therapeutic antibodies often fail to distinguish between malignant T-cells and healthy immune cells, causing systemic toxicity.
